Abstract
Cleavage of the fifth component of complement yields C5a, a potent neutrophil (PMN) and eosinophil chemoattractant, and modulator of microvascular permeability. Similarly, but to a lesser degree, C3 increases vascular permeability and histamine release. SC-41930 (7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)-propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid), an orally-active antiinflammatory agent was tested in anin vivo model of dermal PMN chemotaxis induced by r-hu-C5a and hu-C3. Intradermal injection of C5a in the guinea pig resulted in a significant dose-dependent influx of PMNs at 4 hours as assessed by the dermal levels of myeloperoxidase (MPO). SC-41930 (20 mg/kg) given orally to guinea pigs with intradermal injections of 1 μg C5a significantly (p<0.001) reduced dermal MPO content. SC-41930 was less potent against C3, requiring 40 mg/kg to significantly reduce dermal MPO levels. Agents such as SC-41930, which nullify complement's proinflammatory properties, may well have therapeutic potential.
Similar content being viewed by others
References
P. J. Jose,Complement-derived peptide mediators of inflammation. Brit. Med. Bull.43, 336–349 (1987).
R. L. Shone, S. W. Djuric, B. S. Tsai, D. J. Fretland, T. S. Gaginella and C. S. Cook,SC-41930. Drugs of the Future15, 695–697 (1990).
P. Bradley, D. Priebat, R. Christensen and G. Rothstein,Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol.78, 206–209 (1982).
M. Mason and D. VanEpps,In vivo neutrophil emigration in response to interleukin-1 and tumor necrosis factor alpha. J. Leukocyte Biol.45, 62–68 (1989).
B. Tsai, D. Price, R. Reith, J. Zemaitis, R. Bauer, R. Leonard, S. Djuric and R. Shone,SC-41930: an inhibitor of leukotriene B4 stimulated neutrophil functions. Prostaglandins38, 655–674 (1989).
R. McMillan and S. Forster,Leukotriene B4 and inflammatory disease. Agents and Actions24, 114–119 (1988).
R. Marks, R. Todd and P. Ward,Rapid induction of neutrophil-endothelial adhesion by complement fixation. Nature339, 314–317 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fretland, D.J., Widomski, D.L., Anglin, C.P. et al. Modulation of the chemotactic properties of complement fragments C5a and C3 by the anti-inflammatory agent, SC-41930. Agents and Actions 34, 5–7 (1991). https://doi.org/10.1007/BF01993222
Issue Date:
DOI: https://doi.org/10.1007/BF01993222